Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Gene Cloning Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 Stranded Gene
  • 1.2.3 Complex Gene
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Gene Cloning Service Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Gene Synthesis
  • 1.3.3 Gene Expression
  • 1.3.4 Gene Therapy
  • 1.3.5 Vaccine Research
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Gene Cloning Service Market Perspective (2017-2028)
• 2.2 Gene Cloning Service Growth Trends by Region
  • 2.2.1 Gene Cloning Service Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Gene Cloning Service Historic Market Size by Region (2017-2022)
  • 2.2.3 Gene Cloning Service Forecasted Market Size by Region (2023-2028)
• 2.3 Gene Cloning Service Market Dynamics
  • 2.3.1 Gene Cloning Service Industry Trends
  • 2.3.2 Gene Cloning Service Market Drivers
  • 2.3.3 Gene Cloning Service Market Challenges
  • 2.3.4 Gene Cloning Service Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Gene Cloning Service Players by Revenue
  • 3.1.1 Global Top Gene Cloning Service Players by Revenue (2017-2022)
  • 3.1.2 Global Gene Cloning Service Revenue Market Share by Players (2017-2022)
• 3.2 Global Gene Cloning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Gene Cloning Service Revenue
• 3.4 Global Gene Cloning Service Market Concentration Ratio
  • 3.4.1 Global Gene Cloning Service Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Gene Cloning Service Revenue in 2021
• 3.5 Gene Cloning Service Key Players Head office and Area Served
• 3.6 Key Players Gene Cloning Service Product Solution and Service
• 3.7 Date of Enter into Gene Cloning Service Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Cloning Service Breakdown Data by Type

• 4.1 Global Gene Cloning Service Historic Market Size by Type (2017-2022)
• 4.2 Global Gene Cloning Service Forecasted Market Size by Type (2023-2028)

5 Gene Cloning Service Breakdown Data by Application

• 5.1 Global Gene Cloning Service Historic Market Size by Application (2017-2022)
• 5.2 Global Gene Cloning Service Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Gene Cloning Service Market Size (2017-2028)
• 6.2 North America Gene Cloning Service Market Size by Country (2017-2022)
• 6.3 North America Gene Cloning Service Market Size by Country (2023-2028)
• 6.4 United States
• 6.5 Canada

7 Europe

• 7.1 Europe Gene Cloning Service Market Size (2017-2028)
• 7.2 Europe Gene Cloning Service Market Size by Country (2017-2022)
• 7.3 Europe Gene Cloning Service Market Size by Country (2023-2028)
• 7.4 Germany
• 7.5 France
• 7.6 U.K.
• 7.7 Italy
• 7.8 Russia
• 7.9 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Gene Cloning Service Market Size (2017-2028)
• 8.2 Asia-Pacific Gene Cloning Service Market Size by Country (2017-2022)
• 8.3 Asia-Pacific Gene Cloning Service Market Size by Country (2023-2028)
• 8.4 China
• 8.5 Japan
• 8.6 South Korea
• 8.7 Southeast Asia
• 8.8 India
• 8.9 Australia

9 Latin America

• 9.1 Latin America Gene Cloning Service Market Size (2017-2028)
• 9.2 Latin America Gene Cloning Service Market Size by Country (2017-2022)
• 9.3 Latin America Gene Cloning Service Market Size by Country (2023-2028)
• 9.4 Mexico
• 9.5 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Gene Cloning Service Market Size (2017-2028)
• 10.2 Middle East & Africa Gene Cloning Service Market Size by Country (2017-2022)
• 10.3 Middle East & Africa Gene Cloning Service Market Size by Country (2023-2028)
• 10.4 Turkey
• 10.5 Saudi Arabia
• 10.6 UAE

11 Key Players Profiles

• 11.1 Thermo Fisher Scientific Inc.
  • 11.1.1 Thermo Fisher Scientific Inc. Company Detail
  • 11.1.2 Thermo Fisher Scientific Inc. Business Overview
  • 11.1.3 Thermo Fisher Scientific Inc. Gene Cloning Service Introduction
  • 11.1.4 Thermo Fisher Scientific Inc. Revenue in Gene Cloning Service Business (2017-2022)
  • 11.1.5 Thermo Fisher Scientific Inc. Recent Development
• 11.2 Eurofins Scientific
  • 11.2.1 Eurofins Scientific Company Detail
  • 11.2.2 Eurofins Scientific Business Overview
  • 11.2.3 Eurofins Scientific Gene Cloning Service Introduction
  • 11.2.4 Eurofins Scientific Revenue in Gene Cloning Service Business (2017-2022)
  • 11.2.5 Eurofins Scientific Recent Development
• 11.3 GenScript
  • 11.3.1 GenScript Company Detail
  • 11.3.2 GenScript Business Overview
  • 11.3.3 GenScript Gene Cloning Service Introduction
  • 11.3.4 GenScript Revenue in Gene Cloning Service Business (2017-2022)
  • 11.3.5 GenScript Recent Development
• 11.4 Merck KGaA
  • 11.4.1 Merck KGaA Company Detail
  • 11.4.2 Merck KGaA Business Overview
  • 11.4.3 Merck KGaA Gene Cloning Service Introduction
  • 11.4.4 Merck KGaA Revenue in Gene Cloning Service Business (2017-2022)
  • 11.4.5 Merck KGaA Recent Development
• 11.5 Takara Bio Inc.
  • 11.5.1 Takara Bio Inc. Company Detail
  • 11.5.2 Takara Bio Inc. Business Overview
  • 11.5.3 Takara Bio Inc. Gene Cloning Service Introduction
  • 11.5.4 Takara Bio Inc. Revenue in Gene Cloning Service Business (2017-2022)
  • 11.5.5 Takara Bio Inc. Recent Development
• 11.6 Charles River Laboratories
  • 11.6.1 Charles River Laboratories Company Detail
  • 11.6.2 Charles River Laboratories Business Overview
  • 11.6.3 Charles River Laboratories Gene Cloning Service Introduction
  • 11.6.4 Charles River Laboratories Revenue in Gene Cloning Service Business (2017-2022)
  • 11.6.5 Charles River Laboratories Recent Development
• 11.7 Lonza
  • 11.7.1 Lonza Company Detail
  • 11.7.2 Lonza Business Overview
  • 11.7.3 Lonza Gene Cloning Service Introduction
  • 11.7.4 Lonza Revenue in Gene Cloning Service Business (2017-2022)
  • 11.7.5 Lonza Recent Development
• 11.8 Sartorius AG
  • 11.8.1 Sartorius AG Company Detail
  • 11.8.2 Sartorius AG Business Overview
  • 11.8.3 Sartorius AG Gene Cloning Service Introduction
  • 11.8.4 Sartorius AG Revenue in Gene Cloning Service Business (2017-2022)
  • 11.8.5 Sartorius AG Recent Development
• 11.9 Creative Biogene
  • 11.9.1 Creative Biogene Company Detail
  • 11.9.2 Creative Biogene Business Overview
  • 11.9.3 Creative Biogene Gene Cloning Service Introduction
  • 11.9.4 Creative Biogene Revenue in Gene Cloning Service Business (2017-2022)
  • 11.9.5 Creative Biogene Recent Development
• 11.10 Cellecta, Inc.
  • 11.10.1 Cellecta, Inc. Company Detail
  • 11.10.2 Cellecta, Inc. Business Overview
  • 11.10.3 Cellecta, Inc. Gene Cloning Service Introduction
  • 11.10.4 Cellecta, Inc. Revenue in Gene Cloning Service Business (2017-2022)
  • 11.10.5 Cellecta, Inc. Recent Development
• 11.11 Synbio Technologies
  • 11.11.1 Synbio Technologies Company Detail
  • 11.11.2 Synbio Technologies Business Overview
  • 11.11.3 Synbio Technologies Gene Cloning Service Introduction
  • 11.11.4 Synbio Technologies Revenue in Gene Cloning Service Business (2017-2022)
  • 11.11.5 Synbio Technologies Recent Development
• 11.12 TransGen Biotech Co., Ltd.
  • 11.12.1 TransGen Biotech Co., Ltd. Company Detail
  • 11.12.2 TransGen Biotech Co., Ltd. Business Overview
  • 11.12.3 TransGen Biotech Co., Ltd. Gene Cloning Service Introduction
  • 11.12.4 TransGen Biotech Co., Ltd. Revenue in Gene Cloning Service Business (2017-2022)
  • 11.12.5 TransGen Biotech Co., Ltd. Recent Development
• 11.13 Dobuss(Canvax)
  • 11.13.1 Dobuss(Canvax) Company Detail
  • 11.13.2 Dobuss(Canvax) Business Overview
  • 11.13.3 Dobuss(Canvax) Gene Cloning Service Introduction
  • 11.13.4 Dobuss(Canvax) Revenue in Gene Cloning Service Business (2017-2022)
  • 11.13.5 Dobuss(Canvax) Recent Development
• 11.14 Azenta US, Inc.
  • 11.14.1 Azenta US, Inc. Company Detail
  • 11.14.2 Azenta US, Inc. Business Overview
  • 11.14.3 Azenta US, Inc. Gene Cloning Service Introduction
  • 11.14.4 Azenta US, Inc. Revenue in Gene Cloning Service Business (2017-2022)
  • 11.14.5 Azenta US, Inc. Recent Development
• 11.15 Macrogen, Inc.
  • 11.15.1 Macrogen, Inc. Company Detail
  • 11.15.2 Macrogen, Inc. Business Overview
  • 11.15.3 Macrogen, Inc. Gene Cloning Service Introduction
  • 11.15.4 Macrogen, Inc. Revenue in Gene Cloning Service Business (2017-2022)
  • 11.15.5 Macrogen, Inc. Recent Development
• 11.16 Codex DNA, Inc.
  • 11.16.1 Codex DNA, Inc. Company Detail
  • 11.16.2 Codex DNA, Inc. Business Overview
  • 11.16.3 Codex DNA, Inc. Gene Cloning Service Introduction
  • 11.16.4 Codex DNA, Inc. Revenue in Gene Cloning Service Business (2017-2022)
  • 11.16.5 Codex DNA, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Summary:

Industry Insights
The global Gene Cloning Service market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Stranded Gene accounting for % of the Gene Cloning Service global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Gene Synthesis segment is altered to an % CAGR throughout this forecast period.
China Gene Cloning Service market size is valued at US$ million in 2021, while the North America and Europe Gene Cloning Service are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gene Cloning Service landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Cloning Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Cloning Service market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Cloning Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Cloning Service market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Gene Cloning Service market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Gene Cloning Service Breakdown Data by Type
Stranded Gene
Complex Gene
Others
Gene Cloning Service Breakdown Data by Application
Gene Synthesis
Gene Expression
Gene Therapy
Vaccine Research
Others
Regional Analysis
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Thermo Fisher Scientific Inc.
Eurofins Scientific
GenScript
Merck KGaA
Takara Bio Inc.
Charles River Laboratories
Lonza
Sartorius AG
Creative Biogene
Cellecta, Inc.
Synbio Technologies
TransGen Biotech Co., Ltd.
Dobuss(Canvax)
Azenta US, Inc.
Macrogen, Inc.
Codex DNA, Inc.
Frequently Asked Questions
What factors will challenge the Gene Cloning Service market growth?
Which end-use segment will expand at the fastest CAGR in the Gene Cloning Service market?
Which are the emerging players in the Gene Cloning Service market?
How concentrated is the Gene Cloning Service market?
Which factors are positively contributing to the Gene Cloning Service market growth?
Which are the novel product innovations in the Gene Cloning Service market?
Which product segment will emerge as the most lucrative in the Gene Cloning Service market?
Which factors are increasing the competition in the Gene Cloning Service market?
Which are the strategic measures taken by the Gene Cloning Service industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Gene Cloning Service market in the coming years?